Platten M - Search Results

1

Inhibition of CD95/CD95L (FAS/FASLG) Signaling with APG101 Prevents Invasion and Enhances Radiation Therapy for Glioblastoma.

Blaes J, Thomé CM, Pfenning PN, Rübmann P, Sahm F, Wick A, Bunse T, Schmenger T, Sykora J, von Deimling A, Wiestler B, Merz C, Jugold M, Haberkorn U, Abdollahi A, Debus J, Gieffers C, Kunz C, Bendszus M, Kluge M, Platten M, Fricke H, Wick W, Lemke D. Blaes J, et al. Among authors: platten m. Mol Cancer Res. 2018 May;16(5):767-776. doi: 10.1158/1541-7786.MCR-17-0563. Epub 2018 Feb 16. Mol Cancer Res. 2018. PMID: 29453321

2

Transforming growth factors beta(1) (TGF-beta(1)) and TGF-beta(2) promote glioma cell migration via Up-regulation of alpha(V)beta(3) integrin expression.

Platten M, Wick W, Wild-Bode C, Aulwurm S, Dichgans J, Weller M. Platten M, et al. Biochem Biophys Res Commun. 2000 Feb 16;268(2):607-11. doi: 10.1006/bbrc.2000.2176. Biochem Biophys Res Commun. 2000. PMID: 10679251

3

Role of TGF-beta in oncogenesis.

Weller M, Wick W, Platten M. Weller M, et al. Among authors: platten m. Microsc Res Tech. 2001 Feb 15;52(4):353. doi: 10.1002/1097-0029(20010215)52:4<353::AID-JEMT1019>3.0.CO;2-U. Microsc Res Tech. 2001. PMID: 11170293 No abstract available.

4

Malignant glioma biology: role for TGF-beta in growth, motility, angiogenesis, and immune escape.

Platten M, Wick W, Weller M. Platten M, et al. Microsc Res Tech. 2001 Feb 15;52(4):401-10. doi: 10.1002/1097-0029(20010215)52:4<401::AID-JEMT1025>3.0.CO;2-C. Microsc Res Tech. 2001. PMID: 11170299 Review.

5

Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis.

Roth W, Isenmann S, Nakamura M, Platten M, Wick W, Kleihues P, Bähr M, Ohgaki H, Ashkenazi A, Weller M. Roth W, et al. Among authors: platten m. Cancer Res. 2001 Mar 15;61(6):2759-65. Cancer Res. 2001. PMID: 11289159

6

Ezrin-dependent promotion of glioma cell clonogenicity, motility, and invasion mediated by BCL-2 and transforming growth factor-beta2.

Wick W, Grimmel C, Wild-Bode C, Platten M, Arpin M, Weller M. Wick W, et al. Among authors: platten m. J Neurosci. 2001 May 15;21(10):3360-8. doi: 10.1523/JNEUROSCI.21-10-03360.2001. J Neurosci. 2001. PMID: 11331365 Free PMC article.

7

N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) inhibits transforming growth factor-beta relesase and reduces migration and invasiveness of human malignant glioma cells.

Platten M, Wild-Bode C, Wick W, Leitlein J, Dichgans J, Weller M. Platten M, et al. Int J Cancer. 2001 Jul 1;93(1):53-61. doi: 10.1002/ijc.1289. Int J Cancer. 2001. PMID: 11391621 Free article.

8

N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) suppresses microglial inducible nitric oxide synthase (iNOS) expression and activity induced by interferon-gamma (IFN-gamma).

Platten M, Wick W, Wischhusen J, Weller M. Platten M, et al. Br J Pharmacol. 2001 Nov;134(6):1279-84. doi: 10.1038/sj.bjp.0704373. Br J Pharmacol. 2001. PMID: 11704648 Free PMC article.

9

Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta.

Wick W, Platten M, Weller M. Wick W, et al. Among authors: platten m. J Neurooncol. 2001 Jun;53(2):177-85. doi: 10.1023/a:1012209518843. J Neurooncol. 2001. PMID: 11716069 Review.

10

SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.

Uhl M, Aulwurm S, Wischhusen J, Weiler M, Ma JY, Almirez R, Mangadu R, Liu YW, Platten M, Herrlinger U, Murphy A, Wong DH, Wick W, Higgins LS, Weller M. Uhl M, et al. Among authors: platten m. Cancer Res. 2004 Nov 1;64(21):7954-61. doi: 10.1158/0008-5472.CAN-04-1013. Cancer Res. 2004. PMID: 15520202

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

384 results

Search Page